Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Proqr Therapeutics (PRQR)

Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Best Momentum Stocks to Buy for October 2nd

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 2:BRF S.A. BRFS: This meat processing company has a Zacks Rank #1 and witnessed the Zacks...

BRFS : 4.29 (+0.94%)
SNAX : 0.8685 (+10.64%)
PRQR : 4.33 (-3.56%)
ProQR: Q2 Earnings Snapshot

ProQR: Q2 Earnings Snapshot

PRQR : 4.33 (-3.56%)
ProQR: Q3 Earnings Snapshot

ProQR: Q3 Earnings Snapshot

PRQR : 4.33 (-3.56%)
ProQR: Q2 Earnings Snapshot

ProQR: Q2 Earnings Snapshot

PRQR : 4.33 (-3.56%)
ProQR: Q1 Earnings Snapshot

ProQR: Q1 Earnings Snapshot

PRQR : 4.33 (-3.56%)
Why Shares of ProQR Therapeutics Dropped on Wednesday

The clinical-stage biotech released fourth-quarter and full-year earnings.

LLY : 917.97 (+0.09%)
PRQR : 4.33 (-3.56%)
Lilly and ProQR to Expand RNA Editing Collaboration

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics N.V. (Nasdaq: PRQR), today announced the expansion of their licensing and...

LLY : 917.97 (+0.09%)
PRQR : 4.33 (-3.56%)
ProQR: Q3 Earnings Snapshot

ProQR: Q3 Earnings Snapshot

PRQR : 4.33 (-3.56%)
ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology Programs

In line with corporate strategy update in April, ProQR to focus exclusively on the development of the Axiomer® RNA editing technology platform across...

PRQR : 4.33 (-3.56%)
ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates

Annual General Meeting of Shareholders to be held on June 30, 2022René Beukema joins management team as Chief Corporate Development Officer and General...

PRQR : 4.33 (-3.56%)

Barchart Exclusives

Is Netflix Stock Heading to $900 After Q3 Earnings?
As Netflix continues to generate solid subscriber growth and ARM, at least one Wall Street analyst expects Netflix stock to reach $900, the Street-high price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar